医薬品ボトル市場- 世界の産業規模、シェア、動向、機会、予測、ボトル別、用途別、エンドユーザー別、地域別、競合別、2020-2030F

医薬品ボトルの世界市場規模は2024年に73億米ドルとなり、2030年までのCAGRは3.90%で、予測期間中に目覚ましい成長が見込まれています。

医薬品ボトルは、医薬品、ワクチン、その他のヘルスケア関連物質などの医薬品の保管、保護、調剤用に設計された専用容器です。これらのボトルは、製造から患者への投与までのライフサイクルを通じて、医薬品の完全性、安全性、有効性を維持する上で重要な役割を果たしています。改ざんや不正アクセスを防止するため、医薬品ボトルは改ざん防止シール、バンド、シュリンクスリーブを使用しています。これらの機能により、パッケージが開封されたり、破損していることがわかります。医薬品ボトルには、薬品名、服用方法、有効期限、ロット番号、製造者の詳細などの重要な情報がラベルされています。ブランディングとラベリングは、製品の識別と規制遵守のために不可欠です。

市場促進要因

技術の進歩

主な市場課題

偽造と製品改ざん

主要市場動向

持続可能な包装

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の医薬品ボトル市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • ボトル別（スポイトボトル、液体ボトル、パッカーボトル）
  • 用途別（スポイト、E-リキッド、リキッド、オーラルケア）
  • エンドユーザー別（化学薬品、調剤薬局、ヘルスケアセンター、医薬品、医薬品包装）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 アジア太平洋地域の医薬品ボトル市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州の医薬品ボトル市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米の医薬品ボトル市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の医薬品ボトル市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの医薬品ボトル市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の医薬品ボトル市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 PESTEL分析

第16章 競合情勢

• Berry Plastics Global Inc.
• Amcor Plc.
• Schott AG
• West Pharmaceuticals Services Inc.
• Gerresheimer AG
• Aptar Group Inc.
• Nipro Corporation
• Becton & Dickinson CO.
• Westrock Company
• O. Berk Company LLC

第17章 戦略的提言

第18章 調査会社について・免責事項

Global Pharmaceutical Bottles Market was valued at USD 7.30 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 3.90% through 2030. Pharmaceutical bottles are specialized containers designed for the storage, protection, and dispensing of pharmaceutical products such as medications, vaccines, and other healthcare-related substances. These bottles play a crucial role in maintaining the integrity, safety, and efficacy of pharmaceutical products throughout their lifecycle, from manufacturing to patient administration. To prevent tampering and unauthorized access, pharmaceutical bottles often incorporate tamper-evident seals, bands, or shrink sleeves. These features indicate if the package has been opened or compromised. Pharmaceutical bottles are labeled with essential information, including the medication name, dosage instructions, expiration date, lot number, and manufacturer details. Branding and labeling are essential for product identification and regulatory compliance.

Key Market Drivers

Technological Advancements

Incorporating RFID (Radio-Frequency Identification) and NFC (Near Field Communication) technology into pharmaceutical bottle caps and labels allows for real-time tracking and monitoring of medication usage. This technology can provide dosage reminders, monitor temperature, and offer tamper-evident features. Advancements in child-resistant packaging technology have led to the development of sophisticated closures that are easy for adults to open but challenging for children. These closures often incorporate features like push-and-turn mechanisms or squeeze-and-turn caps. Tamper-evident seals and features, such as shrink bands and breakable caps, have become more advanced and reliable, ensuring the integrity of pharmaceutical products, and protecting against tampering. Serialization involves the unique identification of each pharmaceutical product and its packaging, typically using 2D barcodes or QR codes. This technology helps in tracking and tracing products throughout the supply chain, reducing the risk of counterfeiting and ensuring product authenticity. High-tech solutions like holograms, color-shifting inks, and specialty printing techniques have been employed to make pharmaceutical bottle labels and packaging resistant to counterfeiting.

Innovations in materials science have led to the development of sustainable packaging materials for pharmaceutical bottles. This includes bio-based plastics, recycled materials, and biodegradable options, reducing the environmental footprint of packaging. To protect the stability of pharmaceutical products, pharmaceutical bottles now come with advanced barrier properties. This helps to maintain the integrity of the contents by preventing moisture, oxygen, and UV light from affecting the medication.

Key Market Challenges

Counterfeiting and Product Tampering

Counterfeit pharmaceutical products can contain incorrect or substandard ingredients, posing serious health risks to patients. Tampered products may be contaminated or otherwise compromised, jeopardizing patient safety. Incidents of counterfeiting and tampering erode trust in pharmaceutical brands and the industry as a whole. Consumers may become wary of purchasing medications, leading to a decrease in patient adherence to prescribed treatments. Pharmaceutical companies are subject to strict regulatory requirements to ensure the safety and authenticity of their products. Failure to prevent counterfeiting and tampering can lead to regulatory non-compliance and legal consequences. The financial implications of counterfeiting and tampering are substantial. Pharmaceutical companies may incur costs related to product recalls, legal actions, and damage control. Additionally, they may experience revenue losses due to reduced sales and damaged brand equity. Incidents of counterfeiting and tampering can disrupt the pharmaceutical supply chain. This can lead to delays in delivering critical medications to patients and healthcare providers, potentially impacting public health during emergencies.

Key Market Trends

Sustainable Packaging

The use of eco-friendly materials for pharmaceutical bottles is on the rise. This includes the development and utilization of bio-based plastics, recycled plastics, and biodegradable materials. These materials reduce the environmental impact of packaging and promote circular economy principles. Sustainable packaging initiatives aim to reduce the use of single-use plastics and minimize plastic waste. Pharmaceutical companies are exploring ways to design bottles that use less plastic while maintaining product integrity and safety. Pharmaceutical bottle manufacturers are designing bottles that are easily recyclable. This encourages recycling efforts and reduces the environmental footprint of pharmaceutical packaging. Lightweight bottle designs are being adopted to reduce transportation costs and energy consumption during shipping. These designs maintain packaging integrity while using fewer resources. Some pharmaceutical companies are exploring reusable and refillable bottle systems, where patients can return empty bottles for refilling. This reduces the need for new packaging and minimizes waste. Sustainable sourcing of materials used in pharmaceutical bottles is a priority. This includes ensuring that raw materials are responsibly and ethically sourced. Sustainable packaging aims to reduce the carbon footprint associated with the production and transportation of pharmaceutical bottles. This is achieved through energy-efficient manufacturing processes and optimizing supply chain logistics. Sustainable packaging must also comply with pharmaceutical regulatory standards to ensure product safety and patient well-being. Growing consumer awareness and demand for sustainable products are pushing pharmaceutical companies to adopt eco-friendly packaging solutions, including sustainable bottles. Many pharmaceutical companies have committed to corporate social responsibility (CSR) initiatives, which include sustainable packaging practices as part of their broader sustainability goals.

Key Market Players

• Berry Plastics Group Inc.
• Amcor Limited
• Gerresheimer AG
• Aptar Pharma
• Westrock Company
• Beckton and Dickinson Co.
• West Pharmaceuticals Services Inc.
• Schott AG
• Nipro Corporation
• O.Berk Company LLC

Report Scope:

In this report, the Global Pharmaceutical Bottles Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Bottles Market, By Bottle:

• Dropper Bottles
• Liquid Bottles
• Packer Bottles

Pharmaceutical Bottles Market, By Application:

• Droppers
• E-Liquid
• Liquid
• Oral Care

Pharmaceutical Bottles Market, By End-User:

• Chemical
• Compounding Pharmacies
• Healthcare Centers
• Pharmaceutical
• Pharmaceutical Packaging

Pharmaceutical Bottles Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Bottles Market.

Available Customizations:

Global Pharmaceutical Bottles Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Bottles Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Bottle (Dropper Bottles, Liquid Bottles, Packer Bottles)
  • 5.2.2. By Application (Droppers, E-Liquid, Liquid, Oral Care)
  • 5.2.3. By End-User (Chemical, Compounding Pharmacies, Healthcare Centers, Pharmaceutical, Pharmaceutical Packaging)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Pharmaceutical Bottles Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Bottle
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Pharmaceutical Bottles Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Bottle
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. India Pharmaceutical Bottles Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Bottle
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Australia Pharmaceutical Bottles Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Bottle
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User
  • 6.3.4. Japan Pharmaceutical Bottles Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Bottle
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End User
  • 6.3.5. South Korea Pharmaceutical Bottles Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Bottle
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End User

7. Europe Pharmaceutical Bottles Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Bottle
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pharmaceutical Bottles Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Bottle
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Pharmaceutical Bottles Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Bottle
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Spain Pharmaceutical Bottles Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Bottle
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Pharmaceutical Bottles Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Bottle
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. United Kingdom Pharmaceutical Bottles Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Bottle
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. North America Pharmaceutical Bottles Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Bottle
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Pharmaceutical Bottles Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Bottle
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Mexico Pharmaceutical Bottles Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Bottle
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Canada Pharmaceutical Bottles Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Bottle
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User

9. South America Pharmaceutical Bottles Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Bottle
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Bottles Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Bottle
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Pharmaceutical Bottles Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Bottle
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Pharmaceutical Bottles Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Bottle
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Pharmaceutical Bottles Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Bottle
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Bottles Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Bottle
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Pharmaceutical Bottles Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Bottle
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Pharmaceutical Bottles Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Bottle
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Pharmaceutical Bottles Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Berry Plastics Global Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Amcor Plc.
  • 16.2.1. Business Overview
  • 16.2.2. Company Snapshot
  • 16.2.3. Products & Services
  • 16.2.4. Financials (In case of listed companies)
  • 16.2.5. Recent Developments
  • 16.2.6. SWOT Analysis
• 16.3. Schott AG
  • 16.3.1. Business Overview
  • 16.3.2. Company Snapshot
  • 16.3.3. Products & Services
  • 16.3.4. Financials (In case of listed companies)
  • 16.3.5. Recent Developments
  • 16.3.6. SWOT Analysis
• 16.4. West Pharmaceuticals Services Inc.
  • 16.4.1. Business Overview
  • 16.4.2. Company Snapshot
  • 16.4.3. Products & Services
  • 16.4.4. Financials (In case of listed companies)
  • 16.4.5. Recent Developments
  • 16.4.6. SWOT Analysis
• 16.5. Gerresheimer AG
  • 16.5.1. Business Overview
  • 16.5.2. Company Snapshot
  • 16.5.3. Products & Services
  • 16.5.4. Financials (In case of listed companies)
  • 16.5.5. Recent Developments
  • 16.5.6. SWOT Analysis
• 16.6. Aptar Group Inc.
  • 16.6.1. Business Overview
  • 16.6.2. Company Snapshot
  • 16.6.3. Products & Services
  • 16.6.4. Financials (In case of listed companies)
  • 16.6.5. Recent Developments
  • 16.6.6. SWOT Analysis
• 16.7. Nipro Corporation
  • 16.7.1. Business Overview
  • 16.7.2. Company Snapshot
  • 16.7.3. Products & Services
  • 16.7.4. Financials (In case of listed companies)
  • 16.7.5. Recent Developments
  • 16.7.6. SWOT Analysis
• 16.8. Becton & Dickinson CO.
  • 16.8.1. Business Overview
  • 16.8.2. Company Snapshot
  • 16.8.3. Products & Services
  • 16.8.4. Financials (In case of listed companies)
  • 16.8.5. Recent Developments
  • 16.8.6. SWOT Analysis
• 16.9. Westrock Company
  • 16.9.1. Business Overview
  • 16.9.2. Company Snapshot
  • 16.9.3. Products & Services
  • 16.9.4. Financials (In case of listed companies)
  • 16.9.5. Recent Developments
  • 16.9.6. SWOT Analysis
• 16.10. O. Berk Company LLC
  • 16.10.1. Business Overview
  • 16.10.2. Company Snapshot
  • 16.10.3. Products & Services
  • 16.10.4. Financials (In case of listed companies)
  • 16.10.5. Recent Developments
  • 16.10.6. SWOT Analysis

17. Strategic Recommendations

18. About Us & Disclaimer